Form 4: Hims & Hers Health Director Anja Manuel Acquires 30,120 Restricted Stock Units

Director Anja Manuel reports acquisition of 30,120 Restricted Stock Units in Hims & Hers Health, Inc. with vesting over a three-year period.

Summary

• On May 8, 2024, Anja Manuel, a director of Hims & Hers Health, Inc., acquired 30,120 Restricted Stock Units (RSUs).
• Each RSU represents the right to receive one share of Class A Common Stock.
• The RSUs vest over a three-year period, with one-third vesting on June 15, 2025, another third on June 15, 2026, and the final third on June 15, 2027.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and aligns director interests with company performance.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs indicates a long-term commitment by the director to the company's success.

Industry Context

This type of equity compensation is common in the tech and healthcare industries to align management's interests with those of shareholders.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice among publicly traded companies, especially in growth-oriented sectors like telehealth.
• Companies like Teladoc Health and Amwell also utilize equity-based compensation to incentivize their directors and key employees.
• The vesting schedule of three years is fairly standard, aligning with typical long-term incentive plans.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, potentially driving long-term value creation.

Key Dates